Amgen (AMGN) Tops Q3 EPS by 47c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $403.39 +0.09%
EPS Growth %: +2.7%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
VFS, PKE, More
EPS Growth %: +2.7%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q3 EPS of $5.58, $0.47 better than the analyst estimate of $5.11. Revenue for the quarter came in at $8.5 billion versus the consensus estimate of $8.51 billion.
GUIDANCE:
Amgen sees FY2024 EPS of $19.20-$20.00, versus the consensus of $19.51. Amgen sees FY2024 revenue of $33-33.8 billion, versus the consensus of $33.2 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alethia Capital Starts TTM Technologies (TTMI) at Overweight, 'A Unique Proxy Standing for USA PCB'
- David Ebrahimzadeh Grant for Real Estate Launches to Support Undergraduate Real Estate Scholars
- Acurx Pharmaceuticals Takes Its Antibiotics Story Global Through a 12-Month Series with New to The Street
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
